170 related articles for article (PubMed ID: 36303539)
1. Prognostic significance of modified lung immune prognostic index in osteosarcoma patients.
He X; Tang F; Zou C; Li L; Wang Y; Kenmegne GR; Zhou Y; Lu M; Min L; Luo Y; Tu C
Front Genet; 2022; 13():972352. PubMed ID: 36303539
[No Abstract] [Full Text] [Related]
2. Lung Immune Prognostic Index Could Predict Metastasis in Patients With Osteosarcoma.
He X; Wang Y; Ye Q; Wang Y; Min L; Luo Y; Zhou Y; Tu C
Front Surg; 2022; 9():923427. PubMed ID: 35874141
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma immune prognostic index can indicate the nature of indeterminate pulmonary nodules and predict the metachronous metastasis in osteosarcoma patients.
He X; Lu M; Hu X; Li L; Zou C; Luo Y; Zhou Y; Min L; Tu C
Front Oncol; 2022; 12():952228. PubMed ID: 35936683
[TBL] [Abstract][Full Text] [Related]
4. A novel model for predicting the prognosis of postoperative intrahepatic cholangiocarcinoma patients.
Lv Y; Liu H; He P; Xie S; Yin X; Cai Y; Wu H
Sci Rep; 2023 Nov; 13(1):19267. PubMed ID: 37935735
[TBL] [Abstract][Full Text] [Related]
5. [Effect of dNLR and LIPI scores on the prognosis of elderly patients with non-surgical treatment of non-small cell lung cancer].
Xie JH; Liu MM; Sun NN; Zhang L; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 2022 Sep; 44(9):975-980. PubMed ID: 36164700
[No Abstract] [Full Text] [Related]
6. Prognostic Significance of the Lung Immune Prognostic Index in Patients with Resected Esophageal Squamous Cell Carcinoma.
Feng JF; Zhao JM; Chen S; Chen QX
Cancer Manag Res; 2021; 13():2811-2819. PubMed ID: 33814930
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Predictive and Prognostic Importance of Lung Immune Prognostic Index in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
Arıkan R; Alkış H; Işık S; Yaşar A; Çelebi A; Majidova N; Sever N; Adlı M; Demircan NC
Cureus; 2023 Jun; 15(6):e40548. PubMed ID: 37465788
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy.
Li L; Pi C; Yan X; Lu J; Yang X; Wang C; Li X; Zhang S; Zhang Z; Sun Y; Hu Y
Front Oncol; 2021; 11():697865. PubMed ID: 34692478
[TBL] [Abstract][Full Text] [Related]
9. Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer.
Sonehara K; Tateishi K; Komatsu M; Yamamoto H; Hanaoka M
Thorac Cancer; 2020 Jun; 11(6):1578-1586. PubMed ID: 32286017
[TBL] [Abstract][Full Text] [Related]
10. Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Index Score.
Pan Y; Si H; Jia R; Deng G; Yan H; Fan M; Gou M; Chen S; Zhang N; Shi Y; Qian N; Dai G
J Oncol; 2022; 2022():1427779. PubMed ID: 35342416
[TBL] [Abstract][Full Text] [Related]
11. [Predictive Value of LIPI and iSEND Immune Scoring System
in Immunotherapy of Advanced Non-small Cell Lung Cancer].
Luo Y; Wang X; Wang Y; Zhang G
Zhongguo Fei Ai Za Zhi; 2022 Nov; 25(11):803-810. PubMed ID: 36419394
[TBL] [Abstract][Full Text] [Related]
12. Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection.
Zhou Q; Deng G; Wang Z; Dai G
Front Surg; 2022; 9():1002075. PubMed ID: 36684178
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Serum Biomarkers in Stage IV Non-Small-Cell Lung Cancer Treated with PD-1 Inhibitors: LIPI Score, NLR, dNLR, LMR, and PAB.
Chen J; Wei S; Zhao T; Zhang X; Wang Y; Zhang X
Dis Markers; 2022; 2022():7137357. PubMed ID: 35945957
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy.
Obayashi K; Miki J; Fukuokaya W; Yanagisawa T; Kimura S; Tsuzuki S; Kimura T; Egawa S
Int J Clin Oncol; 2022 Feb; 27(2):396-402. PubMed ID: 34714458
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment Lung Immune Prognostic Index Is a Prognostic Marker of Chemotherapy and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.
Minami S; Ihara S; Komuta K
World J Oncol; 2019 Feb; 10(1):35-45. PubMed ID: 30834050
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment lung immune prognostic index as a biomarker in advanced non-small-cell lung cancer patients receiving first line pembrolizumab.
Veccia A; Sforza V; Vattemi E; Inno A; Kinspergher S; Dipasquale M; Gori S; Morabito A; Baldi I; Caffo O
Immunotherapy; 2021 Sep; 13(13):1093-1103. PubMed ID: 34190578
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma.
Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ
Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer.
Kazandjian D; Gong Y; Keegan P; Pazdur R; Blumenthal GM
JAMA Oncol; 2019 Oct; 5(10):1481-1485. PubMed ID: 31343662
[TBL] [Abstract][Full Text] [Related]
19. Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors.
Chen S; Huang Z; Jia W; Tao H; Zhang S; Ma J; Liu Z; Wang J; Wang L; Cui P; Zhang Z; Huang D; Wu Z; Zheng X; Hu Y
J Hepatocell Carcinoma; 2020; 7():289-299. PubMed ID: 33173757
[TBL] [Abstract][Full Text] [Related]
20. Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy.
Araki T; Tateishi K; Komatsu M; Sonehara K; Kanda S; Hanaoka M; Koizumi T
Thorac Cancer; 2022 Apr; 13(7):1006-1013. PubMed ID: 35156310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
